Osaic Holdings
OVID icon

Osaic Holdings’s Ovid Therapeutics OVID Stock Holding History

Osaic Holdings’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$823 Buy
+306
New +$790 ﹤0.01% 7538
2025
Q4 		– Sell
-5
Closed -$6 – 8071
2025
Q3 		$6 Hold
5
– – ﹤0.01% 7874
2025
Q2 		$1 Hold
5
– – ﹤0.01% 7731
2025
Q1 		$1 Sell
5
-285
-98% -$175 ﹤0.01% 7416
2024
Q4 		$271 Sell
290
-140
-33% -$157 ﹤0.01% 7130
2024
Q3 		$507 Hold
430
– – ﹤0.01% 7010
2024
Q2 		$331 Sell
430
-16
-4% -$45 ﹤0.01% 7085
2024
Q1 		$1.36K Buy
446
+140
+46% +$468 ﹤0.01% 6604
2023
Q4 		$985 Hold
306
– – ﹤0.01% 6765
2023
Q3 		$1.18K Hold
306
– – ﹤0.01% 6784
2023
Q2 		$1K Sell
306
-25
-8% -$85 ﹤0.01% 6880
2023
Q1 		$854 Hold
331
– – ﹤0.01% 7008
2022
Q4 		$1K Hold
331
– – ﹤0.01% 6920
2022
Q3 		$1K Hold
331
– – ﹤0.01% 7031
2022
Q2 		$1K Hold
331
– – ﹤0.01% 7126
2022
Q1 		$1K Hold
331
– – ﹤0.01% 7093
2021
Q4 		$1K Sell
331
-100
-23% -$343 ﹤0.01% 7225
2021
Q3 		$1K Buy
431
+25
+6% +$91 ﹤0.01% 7054
2021
Q2 		$1K Sell
406
-100
-20% -$395 ﹤0.01% 6872
2021
Q1 		$2K Hold
506
– – ﹤0.01% 6507
2020
Q4 		$1K Sell
506
-25
-5% -$117 ﹤0.01% 6248
2020
Q3 		$3K Sell
531
-300
-36% -$2.01K ﹤0.01% 5747
2020
Q2 		$6K Buy
+831
New +$3.89K ﹤0.01% 5411

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Osaic Holdings's OVID Position: Q2 2026 in Review

Osaic Holdings opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 306 shares worth $823. The stake represents ﹤0.01% of the portfolio and ranks #7538 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in OVID as recently as Q3 2025.

Osaic Holdings first reported a position in OVID in Q2 2020 and has held it in 23 quarters since. The position peaked at $6K in Q2 2020. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Osaic Holdings held 306 shares of Ovid Therapeutics worth $823 as of Q2 2026.
  • Ovid Therapeutics was a new Osaic Holdings position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7538 holding.
  • Osaic Holdings first reported a position in Ovid Therapeutics in Q2 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Ovid Therapeutics position peaked at $6K in Q2 2020.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.